Does BROLUCIZUMAB-DBLL Cause Vitreous floaters? 479 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 479 reports of Vitreous floaters have been filed in association with BROLUCIZUMAB-DBLL. This represents 17.1% of all adverse event reports for BROLUCIZUMAB-DBLL.
479
Reports of Vitreous floaters with BROLUCIZUMAB-DBLL
17.1%
of all BROLUCIZUMAB-DBLL reports
4
Deaths
18
Hospitalizations
How Dangerous Is Vitreous floaters From BROLUCIZUMAB-DBLL?
Of the 479 reports, 4 (0.8%) resulted in death, 18 (3.8%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 479 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
Anterior chamber cell (199)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
LEVOFLOXACIN (93)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Vitreous floaters Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM